Basit öğe kaydını göster

dc.contributor.authorAydın, Cihan
dc.contributor.authorAlpsoy, Şeref
dc.contributor.authorAkyüz, Aydın
dc.contributor.authorÖzkaramanlı Gür, Demet
dc.contributor.authorEmlek, Nadir
dc.contributor.authorŞahin, Ayhan
dc.contributor.authorGültekin, Ahmet
dc.contributor.authorAykaç, Hüseyin
dc.date.accessioned2022-11-21T07:40:47Z
dc.date.available2022-11-21T07:40:47Z
dc.date.issued2022en_US
dc.identifier.citationAydin, C., Alpsoy, Ş., Akyüz, A., Özkaramanli Gür, D., Emlek, N., Şahin, A., Gültekin, A., & Aykaç, H. (2022). Could the systemic immune-inflammation index be a predictor to estimate cerebrovascular events in hypertensive patients?. Blood pressure monitoring, 27(1), 33–38. https://doi.org/10.1097/MBP.0000000000000560en_US
dc.identifier.issn1359-5237
dc.identifier.issn1473-5725
dc.identifier.urihttps://doi.org/10.1097/MBP.0000000000000560
dc.identifier.urihttps://hdl.handle.net/11436/7089
dc.description.abstractBackground and objectives Hypertension is one of the most important risk factors for cardiovascular and cerebrovascular events. Inflammatory processes occupy an important place in the pathogenesis of hypertension. Many studies have studied inflammatory markers responsible for the onset of hypertension and organ damage. In this study, we investigated whether the systemic immune-inflammation index (SII) (platelet x neutrophil/lymphocyte), - one of the new inflammatory markers - can be used to predict cerebrovascular events in hypertensive patients. Methods Ambulatory blood pressure monitoring results between January 2019 and June 2020 of approximately 379 patients followed up with hypertension were retrospectively analyzed. These patients were divided into two groups as with or without a previous cerebrovascular event in the analyzed database. In all patients, complete blood count and biochemistry test results just before the cerebrovascular event were found from the database. SII, atherogenic index, neutrophil-lymphocyte ratio were calculated from the complete blood count. Forty-nine patients with stroke (group 1: 12.9%; mean age: 64.3 +/- 14.6) and 330 patients without stroke (group 2: 87.1%; mean age: 50.8 +/- 14.4). Results Ambulatory blood pressure measurements were lower in group 1. Lipid parameters were also lower in this group. Receiver operating characteristic curve analysis showed that SII had a sensitivity of 85.7% and specificity of 84.8 % for stroke in individuals who participated in the study when the cutoff value of SII was 633.26 x 10(3) (P = 0.0001) area under curve (95%); 0.898 (0.856-0.941). In multivariate logistic regression analysis, age and SII were significantly associated with a higher risk of stroke. Age, (hazard ratio:1.067; 95% CI, 1.021-1.115), SII (hazard ratio:1.009; 95% CI, 1.000-1.009), respectively. Conclusions In conclusion, SII is a simple, useful new inflammatory parameter for predicting stroke from hypertension. We found that the high SII levels increase the risk of stroke in hypertensive patients.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBlood pressure monitoringen_US
dc.subjectHypertensionen_US
dc.subjectNeutrophilen_US
dc.subjectLymphocyte ratioen_US
dc.subjectSystemic immune-inflammation indexen_US
dc.titleCould the systemic immune-inflammation index be a predictor to estimate cerebrovascular events in hypertensive patients?en_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorEmlek, Nadir
dc.identifier.doi10.1097/MBP.0000000000000560en_US
dc.identifier.volume27en_US
dc.identifier.issue1en_US
dc.identifier.startpage33en_US
dc.identifier.endpage38en_US
dc.relation.journalBlood Pressure Monitoringen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster